150 related articles for article (PubMed ID: 32246316)
1. Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI.
Takeishi K; Yoshizumi T; Itoh S; Yugawa K; Yoshiya S; Toshima T; Harada N; Ikegami T; Nishie A; Mori M
Ann Surg Oncol; 2020 Sep; 27(9):3344-3353. PubMed ID: 32246316
[TBL] [Abstract][Full Text] [Related]
2. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
3. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
4. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
[TBL] [Abstract][Full Text] [Related]
5. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
[TBL] [Abstract][Full Text] [Related]
6. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
[TBL] [Abstract][Full Text] [Related]
7. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
Lee DH; Lee JM; Yu MH; Hur BY; Yi NJ; Lee KW; Suh KS; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2019 Jun; 29(6):3122-3131. PubMed ID: 30643939
[TBL] [Abstract][Full Text] [Related]
8. Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.
Matsuda M; Tsuda T; Yoshioka S; Murata S; Tanaka H; Hirooka M; Hiasa Y; Mochizuki T
Jpn J Radiol; 2014 Jul; 32(7):405-13. PubMed ID: 24854900
[TBL] [Abstract][Full Text] [Related]
9. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.
Inoue T; Hyodo T; Korenaga K; Murakami T; Imai Y; Higaki A; Suda T; Takano T; Miyoshi K; Koda M; Tanaka H; Iijima H; Ochi H; Hirooka M; Numata K; Kudo M
J Gastroenterol; 2016 Feb; 51(2):144-52. PubMed ID: 26373860
[TBL] [Abstract][Full Text] [Related]
10. Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.
Briani C; Di Pietropaolo M; Marignani M; Carbonetti F; Begini P; David V; Iannicelli E
J Gastrointest Cancer; 2018 Sep; 49(3):302-310. PubMed ID: 28547117
[TBL] [Abstract][Full Text] [Related]
11. Progression of Hepatic Hypovascular Nodules with Hypointensity in the Hepatobiliary Phase of Gd-EOB-DTPA-enhanced MRI in Hepatocellular Carcinoma Cases.
Saitoh T; Sato S; Yazaki T; Tobita H; Miyake T; Ishihara S; Katsube T; Kitagaki H; Kinoshita Y
Intern Med; 2018 Jan; 57(2):165-171. PubMed ID: 29033416
[TBL] [Abstract][Full Text] [Related]
12. Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection.
Toyoda H; Yasuda S; Shiota S; Sone Y; Maeda A; Kaneoka Y; Kumada T; Tanaka J
Eur Radiol; 2022 Jul; 32(7):5016-5023. PubMed ID: 35142900
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of hepatocellular carcinoma development after sustained virologic response in HCV infection.
Toyoda H; Yasuda S; Shiota S; Sone Y; Maeda A; Kaneoka Y; Kumada T; Tanaka J
Aliment Pharmacol Ther; 2021 Jun; 53(12):1309-1316. PubMed ID: 33896023
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging.
Song KD; Rhim H; Lee MW; Kim YS; Kang TW
Acta Radiol; 2017 Jul; 58(7):778-785. PubMed ID: 27903759
[TBL] [Abstract][Full Text] [Related]
15. Differences in the Diagnosis and Treatment of Patients with Early-Stage Hepatocellular Liver Cancer by Multi-Row Spiral CTMDCT and Gd-EOB-DTPA-Enhanced MRI.
Wang K; Jin X; Zhou J; Wang Z; Zhang X
Altern Ther Health Med; 2024 Jan; 30(1):31-35. PubMed ID: 37773658
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
[TBL] [Abstract][Full Text] [Related]
17. The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma.
Wang F; Numata K; Chuma M; Nihonmatsu H; Moriya S; Nozaki A; Ogushi K; Fukuda H; Okada M; Ruan L; Luo W; Koizumi N; Nakano M; Otani M; Inayama Y; Maeda S
Abdom Radiol (NY); 2021 Jun; 46(6):2527-2539. PubMed ID: 33388895
[TBL] [Abstract][Full Text] [Related]
18. Hypointense hepatocellular nodules on hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI: can increasing the flip angle improve conspicuity of lesions?
Tamada T; Ito K; Yamamoto A; Yasokawa K; Higaki A; Kanki A; Sato T; Tanimoto D; Higashi H
J Magn Reson Imaging; 2013 May; 37(5):1093-9. PubMed ID: 23148032
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement: are they at risk of HCC recurrence after ablation or surgery? A systematic review and meta-analysis.
Kim TH; Woo S; Han S; Suh CH; Lee DH; Lee JM
Eur Radiol; 2020 Mar; 30(3):1624-1633. PubMed ID: 31776747
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
